Friday, June 18, 2021

News

Survey Finds Family Travel a Top Priority for Americans This Year

In an online survey of 1,005 Americans, produced by independent creative market research agency Atomik Research, 72% of participants said they will prioritize traveling to see family and friends, with three-fourths agreeing they are likely to do so...

Former President Obama cheers on Joe Biden on 11th Anniversary of Affordable Care Act

Today, behind some democrats led cheers, the focus shifted towards how the rescue plan will help Americans save in regards to their health care.

World’s first oral vaccine to fight the pandemic in the works

Researchers may have a real shot at creating an oral COVID-19 vaccine, one that can protect against variants.  A pill can be self-administered anywhere, anytime providing access to those in remote locations and the most vulnerable who...

LeBron James To Launch MTN DEW RISE ENERGY Drink

Every morning is a chance to seize the day and close the gap between intention and motivation. No one embodies this mentality better than NBA icon, businessman and philanthropist LeBron James, an integral partner behind the launch of...

BioBiz: Pfizer and BioN Tech says 94% effective; Biohaven Pharma slapped by FDA with Kardashian ads

Citing data from Israel, Pfizer and BioNTech said their COVID-19 vaccine was 94% effective in preventing asymptomatic infection, but their announcement lacked key details. These new data build upon and confirm previously released data from the Israel Ministry of Health...

Johnson & Johnson COVID-19 vaccine wins FDA approval for emergency use

 The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the...

Johnson & Johnson Requests Emergency Authorization for COVID-19 Vaccine

Pharmaceutical giant, Johnson & Johnson has requested emergency use authorization from the Food and Drug Administration. The company submitted its application Thursday for the company's single-dose inoculation. In a statement to the press, the...

UK Study: Single dose of AstraZeneca vaccine drastically cuts COVID-19 transmission

A new study out of the United Kingdom showed that a single dose of the COVID-19 vaccine developed by Oxford University and AstraZeneca provides a high level of protection for 12 weeks. The study results support the...

More than Two-Thirds of Americans Feel More Anxious When Experiencing Any Negative Health Symptom

For many Americans, living through 2020 has caused a dramatic shift in priorities, with their health, and the health of their loved ones especially, rising to the top as the most important concern. In fact, a nationally...

Prime Minister orders new COVID lockdown for England

Prime Minister Boris Johnson announced yesterday a new national lockdown for the UK until at least mid-February to combat a fast-spreading new variant of the coronavirus, even as the UK sped up its vaccination program by becoming...
- Advertisement -

Latest News

“Can’t Cancel Pride” relief benefit special draws out big names in entertainment

Kylie Minogue, Leslie Odom Jr., Olly Alexander from Years & Years and Yola will join previously announced performers Bebe...
- Advertisement -

BioBiz: Amgen Inc received approval from The U.S. Food and Drug Administration for Lumakras

Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for...

Amazon signs agreement to Acquire MGM for $8.45 Billion

Amazon announced today that it will acquire the Metro Goldwyn Mayer’s (MGM) for $8.45 billion, significantly enhancing its online content strategy.

Oatly stock soars nearly 30 percent during the company’s public market

Shares of the oat milk brand Oatly soared nearly 30 percent during the company’s public market debut Thursday. The stock...

BioBiz: Bristol Myers Squibb to Pay Up to $1.38 Billion to License Agenus’ Oncology Drug

Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38...